性别确认手术市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

变性手术市场预计在预测期内（2022 年至 2027 年）将以 12.2% 的复合年增长率增长。

COVID-19 正在影响所研究市场的增长速度。 美国整形与重建外科学会 2020 年 5 月发表的一篇题为“COVID-19 对性别不安患者的影响”的文章指出，变性手术被视为择期手术，因此停止或推迟手术。据悉， 还包括一篇整形和重建外科论文，题为“基于 COVID-19 的手术暂停对整形外科实践的影响”。 在 2020 年 8 月公布的“ACAPS 会员调查”中，据报导，32% 的受访者接受过性别确认手术。 另据报导，由于 COVID-19，未进行面部、胸部和生殖器手术。 它还指出，将近 8% 的人回答说性别再确认手术是视情况而定的。 由于 COVID-19 而导致的这些手术的延误影响了大流行期间整个市场的增长。

诸如变性手术意识的增强、性别不安的负担以及政府举措等因素正在推动市场的增长。 例如，美国整形外科医师学会题为《2020 年整形外科统计报告》的报告发现，2020 年美国为跨性别女性进行了 6,368 例性别确认手术，而 2019 年为 5,616 例。据报导，有 另据报导，2020 年，其中 1,102 例是面部手术，4,035 例是乳房或胸部手术，1,231 例是生殖器手术。 此外，根据国际美容外科医生协会2020年的统计数据，2020年全球有9.2%的整形外科医生进行了变性手术。 如此多的性别确认手术表明市场在整个预测期内呈正增长。

各国政府为跨性别健康提供财政支持、平等权利和支持的举措正在推动该细分市场的增长。 例如，2020年11月，印度政府制定实施2019年跨性别者（权利保护）法案的规定，根据该法案，该中心将在每个邦免费提供至少一所政府医院，拟配备提供变性手术和咨询服务。

此外，2021 年 11 月，澳大利亚绿党将承诺每年投入 1500 万美元，用于支付跨性别者和性别多元化者在获得对性别敏感的医疗保健方面产生的自付费用。宣布了投资计划，以Medicare 中永久性的性别敏感护理。 政府和公共机构的此类举措正在推动市场的增长。

但是，高加工成本可能会阻碍预测期内的市场增长。

变性手术市场趋势

预计在预测期内，男性对女性的细分市场将出现显着增长

在预测期内，性别不安负担的增加、变性手术意识的增强、政府的举措以及手术数量的增加等因素正在推动市场增长。

男性性别不安的高患病率导致男性对女性手术的采用，从而推动了细分市场的增长。 例如，Scientific Reports 的一篇题为“瑞典性别不安诊断的有效性和发病率趋势：2021 年 8 月发表的全国登记研究”的论文发现，欧洲、美国和澳大利亚的调查参与者中性别不安的总体患病率是据报导，每万人口中有0.46人，其中男性0.68人，女性0.26人。 如此高的男性性别焦虑症患病率将在预测期内推动变性手术市场的男性到女性部分。

此外，在美国整形外科学会题为“整形外科统计报告”的2020年报告中，2020年美国进行了9,985例男性变性手术，而2019年为8,986例。据报导，有案件 越来越多地采用手术标誌着细分市场的增长。

此外，政府机构的支持也在推动市场的增长。 例如，根据 2022 年 3 月的最新消息，新西兰卫生部报告称，性别确认（生殖器）手术服务的成立是为了让更多的跨性别者能够在新西兰获得公共资助的性别确认性生殖器手术。我在这里。 该服务已在 2019 年预算中批准了四年的 299 万美元，以补充来自高成本治疗池的资金分配，用于确认性别的生殖器手术。 这笔资金预计每年最多可以进行 14 次手术。 来自各个政府机构的这种支持正在推动市场的增长。

因此，由于上述因素，预计该细分市场在预测期内将出现可观的增长。

北美将在市场中占有重要地位，预计在预测期内也会如此

由于性别不安的负担不断增加、变性手术的意识和采用率不断提高以及政府和公共机构的支持，预计北美地区将在变性手术市场中占据重要份额。

在该地区进行的手术数量不断增加表明该地区的市场正在增长。 例如，美国疾病控制与预防中心 2021 年 7 月更新的一篇题为“跨性别者和性别多样化的人”的文章报告说，美国每年大约进行 9,000 例跨性别手术。。 最新统计数据还显示，0.6% 的美国人口被确定为变性人，近 10.9% 的变性医疗经历导致性别确认手术。 如此多的手术表明市场的显着增长。

此外，政府对外科手术的护理和财政支持等支持也在推动市场的增长。 例如，2021 年 6 月，退伍军人事务部 (VA) 部长丹尼斯·麦克唐纳 (Dennis McDonagh) 在佛罗里达州举行的 Pride 活动中宣布，美国政府将首次允许变性退伍军人通过医疗保险进行性别确认手术。) 报导了这一变化。 到目前为止，仅涵盖激素治疗和心理健康服务。 这些政府措施正在推动市场的增长。

因此，由于上述因素，预计北美地区在预测期内将出现增长。

其他好处

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第一章介绍

• 研究假设和市场定义
• 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动力
  • 性别认同障碍的负担越来越重，跨性别相关问题的意识越来越强
  • 政府举措的增加
• 市场製约因素
  • 手术费用高
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分

• 按手术类型
  • 男变女
  • 从女性到男性
• 按地区
  • 北美
  • 欧洲
  • 亚太地区
  • 中东
  • 南美洲

第六章竞争格局

• 公司简介
  • Mount Sinai
  • Boston Medical Center
  • Rumer Cosmetic Surgery
  • Cedar sinai
  • CNY Cosmetic & ReConstructive Surgery
  • Plastic Surgery Group By Rochester
  • Amish Hospital
  • The London Transgender Clinic
  • IM Gender Clinic
  • GRS Montreal Inc.
  • Phuket Plastic Surgery Institute

第7章 市场机会今后动向

The sex reassignment surgery market is expected to witness a CAGR of 12.2% over the forecast period (2022-2027).

COVID-19 has impacted the growth pace of the studied market. The American Society of Plastic Surgeons article titled "The Impact of COVID-19 on Gender Dysphoria Patients" published in May 2020 reported that since gender-affirming surgeries are considered one of the elective surgeries, they have been halted or delayed. Additionally, the Plastic and Reconstructive Surgery article titled "The Impact of COVID-19-based Suspension of Surgeries on Plastic Surgery Practices: A Survey of ACAPS Members" published in August 2020, reported that 32% of the studied population performed gender affirmation surgery. It also reported that due to COVID-19, face, chest, and genital surgery were not being offered. It also stated that nearly 8% responded that revision sex reaffirmation surgery was a situation-specific scenario. Such delays in surgeries due to COVID-19 has impacted the growth of the overall market over the pandemic phase.

Factors such as growing awareness about sex reassignment surgery and the burden of gender dysphoria coupled with government initiatives are driving the growth of the market. For instance, the American Society of Plastic Surgeons report titled "Plastic Surgery Statistics Report" 2020 reported that in the United States, in 2020, trans females had 6,368 gender confirmation surgeries performed compared to 5,616 in 2019. It was also reported that in 2020, out of these 1,102 facial surgeries, 4,035 breast or chest surgeries, and 1,231 genital surgeries were performed. Furthermore, according to the International Society of Aesthetic Plastic Surgery 2020 statistics, 9.2 percent of plastic surgeons worldwide performed sex reassignment surgery in 2020. Such a high number of sex confirmation surgeries demonstrates the positive growth of the market throughout the forecast period.

The rising government initiatives of different countries to provide financial aid, equal rights, and support for transgender health are boosting the growth of the market segment. For instance, in November 2020, the government of India framed rules to implement the Transgender Persons (Protection of Rights) Act, 2019, under which the center proposes that at least one government hospital in every state will be equipped to provide free gender reassignment surgery and counseling.

Furthermore, in November 2021, the Australian Greens announced a plan to make gender-affirming healthcare a permanent part of Medicare, with a USD 15 million investment per year to cover the out-of-pocket costs incurred by trans and gender-diverse people in accessing gender-affirming healthcare. Such initiatives taken by the government and public organizations are propelling the growth of the market.

However, the high procedural costs may hinder the growth of the market over the forecast period.

Sex Reassignment Surgery Market Trends

Male to Female Segment Of the Market is Expected to Project Significant Growth Over the Forecast Period

Factors such as the growing burden of gender dysphoria, increasing awareness about gender reaffirmation surgeries, initiatives taken by the government, and the rising number of surgeries are driving the growth of the market over the forecast period.

The high prevalence of gender dysphoria among males leads to the adoption of male-to-female surgery and thus drives the growth of the market segment. For instance, the Scientific Reports article titled "Validity of the Gender Dysphoria diagnosis and incidence trends in Sweden: a nationwide register study published in August 2021" reported that the overall prevalence in the studied population in Europe, the United States, and Australia for gender dysphoria was 0.46/10,000 population, of which 0.68 for birth-assigned males and 0.26 for birth-assigned females. Such a high prevalence of gender dysphoria in males drives the male to female segment of the sex reassignment surgery market over the forecast period.

Additionally, the American Society of Plastic Surgeons report titled "Plastic Surgery Statistics Report" 2020 reported that in the United States, in 2020, trans males had 9,985 gender confirmation surgeries performed compared to 8,986 in 2019. This increasing adoption of surgery is demonstrating the growth of the market segment.

The support from government agencies is also propelling the growth of the market. For instance, as per the March 2022 update, the Ministry of Health, New Zealand reported that a Gender Affirming (Genital) Surgery Service had been established to help more transgender people access publicly-funded gender-affirming genital surgery in New Zealand. The service has been funded with USD 2.99 million approved in Budget 2019 over four years to supplement the allocation of funding from the High-Cost Treatment Pool for gender-affirming genital surgeries. This funding is expected to enable the delivery of up to 14 surgeries per year. Such support from different government agencies is boosting the growth of the market.

Thus, owing to the abovementioned factors, the market segment is expected to show considerable growth over the forecast period.

North America Holds Significant Share in Market and Expected To Do Same Over the Forecast Period

The North American region is expected to hold a significant share in the sex reassignment surgery market owing to the rising burden of gender dysphoria, increasing awareness and adoption of gender reassignment surgery, coupled with the support of government and public organizations.

The growing number of surgeries performed in the region demonstrates the growth of the market in the region. For instance, the Center for Disease Control and Prevention article titled "Transgender and Gender Diverse Persons", updated in July 2021, reported that about 9,000 transgender surgeries are being performed annually across the United States. It also reported that the latest statistics indicate that 0.6% of the United States population identifies as transgender, and nearly 10.9% of medical encounters with transsexualism result in gender-affirming surgeries. Such a high number of surgeries performed in the country depicts significant growth in the market.

Additionally, support from the government, such as care and financial aid for surgical procedures, is also propelling the growth of the market. For instance, in June 2021, Department of Veterans Affairs (VA) secretary Denis McDonough reported the change at a Pride event in Florida that the United States government will offer gender confirmation surgery (Gender Affirmation surgery) for transgender veterans through its health care coverage for the first time. Earlier, only hormone therapy and mental health services were covered under this. Such steps taken by the government are propelling the growth of the market.

Thus, owing to the abovementioned factors, the North American region is expected to show growth over the forecast period.

Sex Reassignment Surgery Market Competitor Analysis

The sex reassignment surgery market is a moderately competitive market consisting of a few major players. In terms of market share, private players have a larger share. With the rising government initiatives, market players focusing on the patient-centric approach are major factors propelling the market. Some of the key market players in this market include Mount Sinai, Phuket Plastic Surgery Institute, IM Gender Clinic, CNY Cosmetic and Reconstructive Surgerym, and Boston Medical Center.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions & Market Defination
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Burden of Gender Dysphoria and Rising Awarneness for Transgender Related Problems
  • 4.2.2 Rising Government Initiatives
• 4.3 Market Restraints
  • 4.3.1 High Procedural Cost
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Surgery Type
  • 5.1.1 Male to Female
  • 5.1.2 Female to Male
• 5.2 Geography
  • 5.2.1 North America
  • 5.2.2 Europe
  • 5.2.3 Asia-Pacific
  • 5.2.4 Middle-East
  • 5.2.5 South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Mount Sinai
  • 6.1.2 Boston Medical Center
  • 6.1.3 Rumer Cosmetic Surgery
  • 6.1.4 Cedar sinai
  • 6.1.5 CNY Cosmetic & ReConstructive Surgery
  • 6.1.6 Plastic Surgery Group By Rochester
  • 6.1.7 Amish Hospital
  • 6.1.8 The London Transgender Clinic
  • 6.1.9 IM Gender Clinic
  • 6.1.10 GRS Montreal Inc.
  • 6.1.11 Phuket Plastic Surgery Institute

7 MARKET OPPORTUNITIES AND FUTURE TRENDS